1.Factors associated with Experience of Diagnosis and Utilization of Chronic Diseases among Korean Elderly : Focus on Comparing between Urban and Rural Elderly
Min Ji LEE ; Dong Hyun KOWN ; Yong Yook KIM ; Jae Han KIM ; Sung Jun MOON ; Keon Woo PARK ; Il Woo PARK ; Jun Young PARK ; Na Yeon BAEK ; Gi Seok SON ; So Yeon AHN ; In Uk YEO ; Sang Ah WOO ; Sung Yun YOO ; Gi Beop LEE ; Soo Beom LIM ; Soo Hyun JANG ; Su Jin JEONG ; Yeon Ju JUNG ; Seong Geon CHO ; Jeong Sik CHA ; Ki Seok HWANG ; Tae Jun LEE ; Moo Sik LEE
Journal of Agricultural Medicine & Community Health 2019;44(4):165-184
OBJECTIVES:
The purpose of this study was to identify and compare the difference and related factors with general characteristic and health behaviors, a experience of diagnosis and treatment of chronic diseases between rural and urban among elderly in Korea.
METHODS:
We used the data of Community Health Survey 2017 which were collected by the Korean Center for Disease Control and Prevention. The study population comprised 67,835 elderly peopled aged 65 years or older who participated in the survey. The chi-square test, univariate and multivariate logistic regression analysis were used to analyze data.
RESULTS:
We identified many significant difference of health behaviors, an experience of diagnosis and treatment with chronic diseases between rural and urban. Compared to urban elderly, the odds ratios (ORs) (95% confidence interval) of rural elderly were 1.136 (1.092–1.183) for diagnosis of diabetes, 1.278 (1.278–1.386) for diagnosis of dyslipidemia, 0.940 (0.904–0.977) for diagnosis of arthritis, 0.785(0.736–0.837) for treatment of arthritis, 1.159 (1.116–1.203) for diagnosis of cataracts, and 1.285(1.200–1.375) for treatment of cataracts. In the experience of diagnosis and treatment of chronic diseases, various variables were derived as contributing factors for each disease. Especially, there were statistically significant difference in the experience of diabetes diagnosis, arthritis diagnosis, cataract diagnosis and dyslipidemia except for hypertension diagnosis (p<0.01) between urban and rural elderly. There were statistically significant differences in the experience of treatment for arthritis and cataract (p<0.01), but there was no significant difference in the experience of treatment for hypertension, diabetes, dyslipidemia between urban and rural elderly.
CONCLUSION
Therefore, it would be necessary to implement a strategic health management project for diseases that showed significant experience of chronic diseases with diagnosis and treatment, reflecting the related factors of the elderly chronic diseases among the urban and rural areas.
2.Prognosis of Pregnancy-Associated Gastric Cancer: An Age-, Sex-, and Stage-Matched Case-Control Study.
Min Jeong SONG ; Young Soo PARK ; Ho June SONG ; Se Jeong PARK ; Ji Yong AHN ; Kee Don CHOI ; Gin Hyug LEE ; Hwoon Yong JUNG ; Jeong Hwan YOOK ; Byung Sik KIM
Gut and Liver 2016;10(5):731-738
BACKGROUND/AIMS: Pregnancy-associated gastric cancer is a rare condition. This case-control study was performed to identify the clinicopathological features and prognostic factors of pregnancy-associated gastric cancer. METHODS: All consecutive patients who presented to our tertiary referral hospital with pregnancy-associated gastric cancer from 1991 to 2012 were identified. Two age-, sex-, and stage-matched controls for each case were also identified from the records. Clinicopathological, gynecological, and oncological outcomes were recorded. Immunohistochemical staining was performed for estrogen receptor, progesterone receptor, epidermal growth factor receptor, human epidermal growth factor receptor, and E-cadherin. Fluorescence in situ hybridization was performed for fibroblast growth factor receptor 2. RESULTS: The median overall survival rates of the pregnancy-associated gastric cancer and control groups were 7.0 months and 15.0 months, respectively (p=0.189). Poor prognostic factors included advanced stage and tumor location in the corpus or the entire stomach but not pregnancy status or loss of E-cadherin. Pregnancy-associated gastric cancer was associated with a longer time from diagnosis to treatment (21 days vs 7 days, p=0.021). The two groups did not differ in the expression of the receptors or E-cadherin. CONCLUSIONS: The dismal prognosis of pregnancy-associated gastric cancer may related to the tumor stage and location rather than to pregnancy itself.
Cadherins
;
Case-Control Studies*
;
Diagnosis
;
Estrogens
;
Fluorescence
;
Humans
;
In Situ Hybridization
;
Pregnancy
;
Prognosis*
;
Receptor, Epidermal Growth Factor
;
Receptor, Fibroblast Growth Factor, Type 2
;
Receptors, Progesterone
;
Stomach
;
Stomach Neoplasms*
;
Survival Rate
;
Tertiary Care Centers
3.The Korean Gastric Cancer Cohort Study: Study Protocol and Brief Results of a Large-Scale Prospective Cohort Study.
Bang Wool EOM ; Young Woo KIM ; Byung Ho NAM ; Keun Won RYU ; Hyun Yong JEONG ; Young Kyu PARK ; Young Joon LEE ; Han Kwang YANG ; Wansik YU ; Jeong Hwan YOOK ; Geun Am SONG ; Sei Jin YOUN ; Heung Up KIM ; Sung Hoon NOH ; Sung Bae PARK ; Doo Hyun YANG ; Sung KIM
Journal of Gastric Cancer 2016;16(3):182-190
PURPOSE: This study aimed to establish a large-scale database of patients with gastric cancer to facilitate the development of a national-cancer management system and a comprehensive cancer control policy. MATERIALS AND METHODS: An observational prospective cohort study on gastric cancer was initiated in 2010. A total of 14 cancer centers throughout the country and 152 researchers were involved in this study. Patient enrollment began in January 2011, and data regarding clinicopathological characteristics, life style-related factors, quality of life, as well as diet diaries were collected. RESULTS: In total, 4,963 patients were enrolled until December 2014, and approximately 5% of all Korean patients with gastric cancer annually were included. The mean age was 58.2±11.5 years, and 68.2% were men. The number of patients in each stage was as follows: 3,394 patients (68.4%) were in stage IA/B; 514 patients (10.4%), in stage IIA/B; 469 patients (9.5%), in stage IIIA/B/C; and 127 patients (2.6%), in stage IV. Surgical treatment was performed in 3,958 patients (79.8%), endoscopic resection was performed in 700 patients (14.1%), and 167 patients (3.4%) received palliative chemotherapy. The response rate for the questionnaire on the quality of life was 95%; however, diet diaries were only collected for 27% of patients. CONCLUSIONS: To provide comprehensive information on gastric cancer for patients, physicians, and government officials, a large-scale database of Korean patients with gastric cancer was established. Based on the findings of this cohort study, an effective cancer management system and national cancer control policy could be developed.
Cohort Studies*
;
Diet
;
Drug Therapy
;
Humans
;
Korea
;
Male
;
Occupational Groups
;
Prospective Studies*
;
Quality of Life
;
Stomach Neoplasms*
4.Fistula Formation between Right Upper Bronchus and Bronchus Intermedius Caused by Endobronchial Tuberculosis: A Case Report.
Mikyoung KIM ; Eun Seok KANG ; Jin Yong PARK ; Hwa Rim KANG ; Jee Hyun KIM ; Youjin CHANG ; Kang Hyeon CHOI ; Ki Man LEE ; Yook KIM ; Jin Young AN
Tuberculosis and Respiratory Diseases 2015;78(3):286-288
Endobronchial tuberculosis is defined as a tuberculous infection of the tracheobronchial tree and has a prevalence of up to 50% in active pulmonary tuberculosis cases. The most common complication of endobronchial tuberculosis is bronchial stenosis; benign fistula formation by endobronchial tuberculosis is rare, especially inter-bronchial fistula formation. We reported a rare case of a 73-year-old woman with a fistula between the right upper bronchus and bronchus intermedius. A diagnosis of inter-bronchial fistula caused by endobronchial tuberculosis was based on the results of chest computed tomography scans, bronchoscopy, and microbiological and pathological tests. The patient was treated with anti-tuberculous medication, and her symptoms gradually improved.
Aged
;
Bronchi*
;
Bronchoscopes
;
Bronchoscopy
;
Constriction, Pathologic
;
Diagnosis
;
Female
;
Fistula*
;
Humans
;
Prevalence
;
Thorax
;
Tomography, X-Ray Computed
;
Tuberculosis*
;
Tuberculosis, Pulmonary
5.Delayed Presentation of Catheter-Related Subclavian Artery Pseudoaneurysm.
Hwa Rim KANG ; Jin Yong PARK ; Jee Hyun KIM ; Yook KIM ; Min Ho KANG ; Youjin CHANG ; Kang Hyeon CHOE ; Ki Man LEE ; Jin Young AN
Korean Journal of Critical Care Medicine 2015;30(3):222-226
Central venous catheterization is a common diagnostic and therapeutic procedure in modern clinical practice. Pseudoaneurysms of the subclavian artery are rare and usually occur immediately after the causative event, whether the cause was trauma or a medical procedure. Here we report the rare case of a 71-year-old woman with delayed presentation of catheter-related subclavian pseudoaneurysm. The patient was treated for aspiration pneumonia with respiratory failure in another hospital. The patient's chest wall swelling began two weeks after the initial catheterization in the other hospital, probably because of slow leakage of blood from the injured subclavian artery caused by incomplete compression of the puncture site and uremic coagulopathy. She was successfully treated with ultrasound-guided thrombin and angiography-guided histoacryl injection without stent insertion or surgery. Her condition improved, and she was discharged to her home.
Aged
;
Aneurysm, False*
;
Catheterization
;
Catheterization, Central Venous
;
Catheters
;
Central Venous Catheters
;
Enbucrilate
;
Female
;
Humans
;
Pneumonia, Aspiration
;
Punctures
;
Respiratory Insufficiency
;
Stents
;
Subclavian Artery*
;
Thoracic Wall
;
Thrombin
6.Delayed Presentation of Catheter-Related Subclavian Artery Pseudoaneurysm
Hwa Rim KANG ; Jin Yong PARK ; Jee Hyun KIM ; Yook KIM ; Min Ho KANG ; Youjin CHANG ; Kang Hyeon CHOE ; Ki Man LEE ; Jin Young AN
The Korean Journal of Critical Care Medicine 2015;30(3):222-226
Central venous catheterization is a common diagnostic and therapeutic procedure in modern clinical practice. Pseudoaneurysms of the subclavian artery are rare and usually occur immediately after the causative event, whether the cause was trauma or a medical procedure. Here we report the rare case of a 71-year-old woman with delayed presentation of catheter-related subclavian pseudoaneurysm. The patient was treated for aspiration pneumonia with respiratory failure in another hospital. The patient's chest wall swelling began two weeks after the initial catheterization in the other hospital, probably because of slow leakage of blood from the injured subclavian artery caused by incomplete compression of the puncture site and uremic coagulopathy. She was successfully treated with ultrasound-guided thrombin and angiography-guided histoacryl injection without stent insertion or surgery. Her condition improved, and she was discharged to her home.
Aged
;
Aneurysm, False
;
Catheterization
;
Catheterization, Central Venous
;
Catheters
;
Central Venous Catheters
;
Enbucrilate
;
Female
;
Humans
;
Pneumonia, Aspiration
;
Punctures
;
Respiratory Insufficiency
;
Stents
;
Subclavian Artery
;
Thoracic Wall
;
Thrombin
7.Infratentorial and Intraparenchymal Subependymoma in the Cerebellum: Case Report.
Yook KIM ; Seung Young LEE ; Kyung Sik YI ; Sang Hoon CHA ; Min Ho GANG ; Bum Sang CHO ; Yong Moon LEE
Korean Journal of Radiology 2014;15(1):151-155
Subependymomas are rare benign tumors located in the ventricular system. Intraparenchymal subependymoma is extremely rare; only 6 cases have been reported, and all were located in the supratentorial region. We describe a case of infratentorial, intraparenchymal subependymoma in a 28-year-old man with intermittent headache. Imaging revealed a well-demarcated cystic and solid cerebellar mass near the fourth ventricle. The mass had a microcystic component and calcification without contrast enhancement. Complete surgical excision was performed, and histopathology confirmed a subependymoma.
Adult
;
Calcinosis/diagnosis
;
Cerebellar Neoplasms/*diagnosis/surgery
;
Fourth Ventricle
;
Glioma, Subependymal/*diagnosis/surgery
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Rare Diseases/*diagnosis/surgery
;
Tomography, X-Ray Computed
8.Anti-Inflammatory Effect of Mangostenone F in Lipopolysaccharide-Stimulated RAW264.7 Macrophages by Suppressing NF-kappaB and MAPK Activation.
Byoung Ok CHO ; Hyung Won RYU ; Yangkang SO ; Chang Wook LEE ; Chang Hyun JIN ; Hong Sun YOOK ; Yong Wook JEONG ; Jong Chun PARK ; Il Yun JEONG
Biomolecules & Therapeutics 2014;22(4):288-294
Mangostenone F (MF) is a natural xanthone isolated from Garcinia mangostana. However, little is known about the biological activities of MF. This study was designed to investigate the anti-inflammatory effect and underlying molecular mechanisms of MF in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. MF dose-dependently inhibited the production of NO, iNOS, and pro-inflammatory cytokines (TNF-alpha, IL-6, and IL-1beta) in LPS-stimulated RAW264.7 macrophages. Moreover, MF decreased the NF-kappaB luciferase activity and NF-kappaB DNA binding capacity in LPS-stimulated RAW264.7 macrophages. Furthermore, MF suppressed the NF-kappaB activation by inhibiting the degradation of IkappaBalpha and nuclear translocation of p65 subunit of NF-kappaB. In addition, MF attenuated the AP-1 luciferase activity and phosphorylation of ERK, JNK, and p38 MAP kinases. Taken together, these results suggest that the anti-inflammatory effect of MF is associated with the suppression of NO production and iNOS expression through the down-regulation of NF-kappaB activation and MAPK signaling pathway in LPS-stimulated RAW264.7 macrophages.
Cytokines
;
DNA
;
Down-Regulation
;
Garcinia mangostana
;
Interleukin-6
;
Luciferases
;
Macrophages*
;
NF-kappa B*
;
Phosphorylation
;
Phosphotransferases
;
Transcription Factor AP-1
9.Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line.
Yong Yook LEE ; Hwang Phill KIM ; Min Jueng KANG ; Byoung Kyu CHO ; Sae Won HAN ; Tae You KIM ; Eugene C YI
Experimental & Molecular Medicine 2013;45(11):e64-
Lapatinib, a dual inhibitor of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) tyrosine kinases, has shown promising results as a growth inhibitor of HER2-positive cancer cells in vitro. However, similar to other EGFR-targeting drugs, acquired resistance to lapatinib by HER2-positive cancer cells remains a major clinical challenge. To elucidate resistance mechanisms to EGFR/HER2-targeting agents, we performed a systematic quantitative comparison of the phosphoproteome of lapatinib-resistant (LR) human gastric cancer cells (SNU216-LR) versus parental cells (SNU216) using a titanium dioxide (TiO2) phosphopeptide enrichment method and analysis with a Q-Exactive hybrid quadrupole-Orbitrap mass spectrometer. Biological network analysis of differentially expressed phosphoproteins revealed apparent constitutive activation of the MET-axis phosphatidylinositide 3-kinase (PI3K)/alpha-serine/threonine-protein kinase (AKT) and mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) signaling pathways in SNU216-LR. Inhibition of the PI3K/AKT and MAPK/ERK signaling pathways in SNU216-LR also leads to cell cycle arrest, confirming the biological network analysis. Lapatinib sensitivity was restored when cells were treated with several molecular targeting agents in combination with lapatinib. Thus, by integrating phosphoproteomic data, protein networks and effects of signaling pathway modulation on cell proliferation, we found that SNU216-LR maintains constitutive activation of the PI3K/AKT and MAPK/ERK pathways in a MET-dependent manner. These findings suggest that pathway activation is a key compensatory intracellular phospho-signaling event that may govern gastric cancer cell resistance to drug treatment.
Antineoplastic Agents/*pharmacology
;
Cell Line, Tumor
;
Drug Resistance, Neoplasm
;
Humans
;
*MAP Kinase Signaling System
;
Mitogen-Activated Protein Kinase Kinases/metabolism
;
Mitogen-Activated Protein Kinases/metabolism
;
Phosphatidylinositol 3-Kinases/*metabolism
;
Phosphorylation
;
Proteomics
;
Proto-Oncogene Proteins c-akt/*metabolism
;
Proto-Oncogene Proteins c-met/*metabolism
;
Quinazolines/*pharmacology
10.Voiding Dysfunction after Stroke and Traumatic Brain Injury: Multi-center Study.
Sundo KIM ; Yoon Ghil PARK ; Tae Sik YOON ; Kyung Mook SEO ; Shi Uk LEE ; Heedong PARK ; Kyung Jae YOON ; Yong Yook KIM ; Ji Seong HONG
Brain & Neurorehabilitation 2011;4(2):110-115
OBJECTIVE: Voiding dysfunction after stroke and traumatic brain injury has been known to be a predictive factor of death or severe disability, and an important factor on hospital discharge. Thus we aim to investigate its prevalence, related factors and natural course of brain injury related voiding dysfunction for proper rehabilitation after brain injury. METHOD: Two hundred ten brain injury patients (male 130, female 80) admitted in 5 university hospitals were included. The cognitive function was assessed using the Korean version-Mini mental state examination (K-MMSE), and bladder function was evaluated with the International Prostate Symptom Score (IPSS) and voiding diary. We excluded the patients that had previous urologic and gynecologic problem. RESULTS: Overall, 43.7% of total patients had voiding difficulty and the most common symptom was nocturia (80.6%), which was followed by frequency (72.6%) and urgency (40.3%). Patients with incontinence had lower K-MMSE scores than continent patients. There was no significant difference of rate of incontinence in relation with sex, cause of brain injury, and lesion site. Prevalence of urinary symptoms decreased as the duration after brain injury was longer. The quality of life score showed a high correlation with the total IPSS score (p<0.05). CONCLUSION: The overall results demonstrate that voiding dysfunction after brain injury is influenced by onset time and cognitive function after brain injury.
Brain
;
Brain Injuries
;
Female
;
Hospitals, University
;
Humans
;
Nocturia
;
Prevalence
;
Prostate
;
Quality of Life
;
Stroke
;
Urinary Bladder

Result Analysis
Print
Save
E-mail